Insider and congress filings
Abbott Laboratories (ABT)
About Abbott Laboratories
from the company's filings and listing- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- Robert Ford
- Employees
- 115,000
- Listed since
- -
- Market value
- $182.1B
- Price to earnings
- 33.8
- Earnings per share
- $3.11
- Dividend yield
- 2.36%
Earnings
6 reported quarters · next on Oct 21, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Jul 16, 2026 | $1.31 | $1.28 | $12.6B | $12.5B | EPS beatRevenue in line |
| Apr 16, 2026 | $1.15 | $1.14 | $11.2B | $11.0B | EPS in lineRevenue in line |
| Jan 22, 2026 | $1.50 | $1.50 | $11.5B | $11.8B | EPS in lineRevenue miss |
| Oct 15, 2025 | $1.30 | $1.30 | $11.4B | $11.4B | EPS in lineRevenue in line |
| Jul 17, 2025 | $1.26 | $1.26 | $11.1B | $11.1B | EPS in lineRevenue in line |
| Apr 16, 2025 | $1.09 | $1.07 | $10.4B | $10.4B | EPS beatRevenue in line |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way; basis unverified means we could not classify the reported figure. A flag reads n/a only when a number is missing. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for 2025 · proxy filed Mar 13, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Robert B. FordChairman of the Board and Chief Executive Officer | $1.5M | $8.8M | $13.9M | $24.2M |
| Philip P. BoudreauExecutive Vice President, Finance and Chief Financial | $974K | $3.0M | $5.1M | $9.1M |
| Lisa D. EarnhardtExecutive Vice President and Group President, Medical | $924K | $2.5M | $4.6M | $8.1M |
| Christopher J. ScogginsExecutive Vice President, Diabetes Care | $860K | $1.7M | $4.1M | $6.6M |
| Daniel G. SalvadoriExecutive Vice President and Group President, Establis | $924K | $2.2M | $3.4M | $6.5M |
The summary compensation table from the 2025 proxy statement, current executives only. 1 executive who has since left the company is named in that filing and not shown here. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Change | Of company |
|---|---|---|---|---|
| Blackrock, Inc. | $13.8B | 152,563,476 | +4.7% | 8.75% |
| Vanguard Capital Management LLC | $10.3B | 113,750,994 | +0.7% | 6.53% |
| State Street Corp | $7.3B | 80,926,234 | +1.7% | 4.64% |
| Charles Schwab Investment Management Inc | $5.4B | 59,674,507 | +31.2% | 3.42% |
| Sixth Street Partners Management Company, L.P. | $5.4B | 59,674,507 | +100.0% | 3.42% |
| Vanguard Portfolio Management LLC | $4.4B | 49,017,866 | +2.2% | 2.81% |
| Geode Capital Management, LLC | $3.5B | 39,219,337 | +0.2% | 2.25% |
| Capital Research Global Investors | $3.3B | 36,908,990 | -25.8% | 2.12% |
| Capital International Investors | $3.1B | 34,654,113 | -7.6% | 1.99% |
| Morgan Stanley | $2.4B | 26,611,315 | -11.6% | 1.53% |
| Norges Bank | $2.1B | 23,354,911 | +100.0% | 1.34% |
| Price T Rowe Associates Inc | $2.1B | 22,787,202 | +31.9% | 1.31% |
A 13F reports long US equity positions 45 days after the quarter ends, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
13 filings of 373 on record| Insider | Action | Shares | Price | Value | Trade date | Delay |
|---|---|---|---|---|---|---|
| John A. Mccoy Jr.Vice President and Controller | Sold | 27 | $109.54 | $3K | Sep 2, 2026 | 1d |
| Robert B. FordChairman and CEO | Sold · 2 lines | 398,832 | $115.85 | $46.2M | Aug 25, 2026 | 2d |
| Louis H. MorroneExecutive Vice President | Sold | 5,850 | $109.83 | $643K | Aug 11, 2026 | 2d |
| John G. StrattonDirector | Bought | 2,000 | $86.82 | $174K | May 7, 2026 | 42d |
| Daniel J. StarksDirector | Bought | 10,000 | $92.65 | $927K | Apr 27, 2026 | 1d |
| Philip P. BoudreauEVP and CFO | Bought | 2,200 | $91.50 | $201K | Apr 23, 2026 | 4d |
| Elizabeth C. CushmanEVP, GC and Secretary | Sold | 263 | $115.58 | $30K | Mar 2, 2026 | 1d |
| John A. Mccoy Jr.Vice President and Controller | Sold | 585 | $115.58 | $68K | Mar 2, 2026 | 1d |
| Mary K. MorelandExecutive Vice President | Sold | 613 | $115.58 | $71K | Mar 2, 2026 | 1d |
| Louis H. MorroneExecutive Vice President | Sold | 1,144 | $115.58 | $132K | Mar 2, 2026 | 1d |
| Daniel Gesua Sive SalvadoriEVP and Group President | Sold | 885 | $115.58 | $102K | Mar 2, 2026 | 1d |
| Eric ShroffSenior Vice President | Sold | 709 | $115.58 | $82K | Mar 2, 2026 | 1d |
| Daniel J. StarksDirector | Bought · 2 lines | 10,000 | $108.73 | $1.1M | Feb 4, 2026 | 2d |
One row is one filing. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count.
Congress trades in ABT
20 disclosures of 252 on record · median 25d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Rick W. AllenSpouse | Stock | Sale | $15,001 - $50,000 | +18.3%S&P +1.4% · vs S&P 500 +16.9% | Jul 14, 2026 | Aug 18, 2026 | 35d |
| Richard McCormick | Stock | Sale | $1,001 - $15,000 | -0.4%S&P +2.8% · vs S&P 500 -3.2% | Jul 30, 2026 | Aug 14, 2026 | 15d |
| Mike KellySpouse | Stock | Sale | $1,001 - $15,000 | +4.5%S&P +2.6% · vs S&P 500 +1.9% | Jul 17, 2026 | Aug 12, 2026 | 26d |
| Alan ArmstrongSelfFiled late | Stock | Sale (Full) | $15,001 - $50,000 | +1.2%S&P +20.2% · vs S&P 500 -19.0% | Mar 27, 2026 | Jul 21, 2026 | 116d |
| Rick Larsen | Stock | Sale | $1,001 - $15,000 | +10.6%S&P +2.3% · vs S&P 500 +8.3% | Jul 8, 2026 | Jul 12, 2026 | 4d |
| Richard McCormick | Stock | Purchase | $1,001 - $15,000 | +19.3%S&P +2.8% · vs S&P 500 +16.6% | Jun 12, 2026 | Jul 9, 2026 | 27d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +21.0%S&P +0.4% · vs S&P 500 +20.6% | Jun 2, 2026 | Jul 6, 2026 | 34d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +16.2%S&P +3.6% · vs S&P 500 +12.6% | Jun 23, 2026 | Jul 6, 2026 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +16.0%S&P +2.1% · vs S&P 500 +13.9% | Jun 30, 2026 | Jul 6, 2026 | 6d |
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | +16.1%S&P +1.6% · vs S&P 500 +14.5% | Jun 16, 2026 | Jul 2, 2026 | 16d |
| Julie JohnsonJoint | Stock | Sale | $1,001 - $15,000 | +24.8%S&P +3.3% · vs S&P 500 +21.5% | May 12, 2026 | Jun 12, 2026 | 31d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | +24.6%S&P +3.2% · vs S&P 500 +21.4% | May 15, 2026 | Jun 9, 2026 | 25d |
| Ro Khanna | Stock | Sale | $15,001 - $50,000 | +23.2%S&P +2.1% · vs S&P 500 +21.1% | May 27, 2026 | Jun 9, 2026 | 13d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | +17.6%S&P +5.8% · vs S&P 500 +11.8% | May 1, 2026 | Jun 9, 2026 | 39d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | +24.6%S&P +3.2% · vs S&P 500 +21.4% | May 15, 2026 | Jun 8, 2026 | 24d |
| Rick W. AllenSpouseFiled late | Stock | Sale | $15,001 - $50,000 | +10.2%S&P +8.7% · vs S&P 500 +1.5% | Apr 16, 2026 | Jun 5, 2026 | 50d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +22.8%S&P +1.6% · vs S&P 500 +21.2% | May 27, 2026 | Jun 3, 2026 | 7d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +4.5%S&P +11.1% · vs S&P 500 -6.6% | Apr 13, 2026 | May 11, 2026 | 28d |
| Laura Friedman | Stock | Exchange | $1,001 - $15,000 | +1.1%S&P +16.4% · vs S&P 500 -15.2% | Mar 24, 2026 | Apr 17, 2026 | 24d |
| Ro Khanna | Stock | Purchase | $15,001 - $50,000 | +0.6%S&P +16.5% · vs S&P 500 -15.8% | Mar 23, 2026 | Apr 7, 2026 | 15d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Members of Congress reporting a position
18 members · estimate, as of Sep 10, 202618 members report a position (estimated). The largest estimated position is in the $250,001 - $500,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| John W. Hickenlooper | Democrat · Senate | $250,001 - $500,000 | 1.4% |
| J. French Hill | Republican · House | $50,001 - $100,000 | 0.6% |
| Pete Sessions | Republican · House | $50,001 - $100,000 | 1.7% |
| Daniel Meuser | Republican · House | $15,001 - $50,000 | 1.8% |
| Thomas H. Kean, Jr. | Republican · House | $15,001 - $50,000 | 0.8% |
| Richard McCormick | Republican · House | $15,001 - $50,000 | 11.0% |
| Gary C. Peters | Democrat · Senate | $15,001 - $50,000 | 0.8% |
| Carol D. Miller | Republican · House | $15,001 - $50,000 | 1.2% |
| Debbie Dingell | Democrat · House | $15,001 - $50,000 | 0.4% |
| Kelly Morrison | Democrat · House | $15,001 - $50,000 | 0.2% |
| Robert Bresnahan | Republican · House | $15,001 - $50,000 | 0.2% |
| Shelley Moore Capito | Republican · Senate | $15,001 - $50,000 | 1.0% |
| Mike Kelly | Republican · House | $15,001 - $50,000 | 0.2% |
| Randy Fine | Republican · House | $1,001 - $15,000 | 0.7% |
| Laura Friedman | Democrat · House | $1,001 - $15,000 | 1.6% |
| Michael A. Rulli | Republican · House | $1,001 - $15,000 | 0.7% |
| Robert B. Aderholt | Republican · House | $1,001 - $15,000 | 0.9% |
| Robert J. Wittman | Republican · House | $1,001 - $15,000 | 0.7% |
A further 1 member reports a position estimated under $1,000; those are not listed.
Estimate, as of Sep 10, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Awards, option exercises and gifts (20)
| Insider | Event | Shares | Date |
|---|---|---|---|
| John A. Mccoy Jr.Vice President and Controller | Tax withholding | 52 | Sep 1, 2026 |
| Philip P. BoudreauEVP and CFO | Tax withholding | 388 | Sep 1, 2026 |
| Robert B. FordChairman and CEO | Option exercise | 398,832 | Aug 25, 2026 |
| Louis H. MorroneExecutive Vice President | Discretionary transaction | 12 | Aug 12, 2026 |
| John G. StrattonDirector | Stock award | 432 | Jun 30, 2026 |
| Nita AhujaDirector | Stock award | 347 | Jun 30, 2026 |
| Patricia Paola GonzalezDirector | Stock award | 363 | Jun 30, 2026 |
| Kevin T. ConroyDirector | Stock award | 231 | Jun 30, 2026 |
| Louis H. MorroneExecutive Vice President | Tax withholding | 269 | Jun 30, 2026 |
| Michael F. RomanDirector | Stock award | 416 | Jun 30, 2026 |
| Elizabeth C. CushmanEVP, GC and Secretary | Tax withholding | 560 | Jun 27, 2026 |
| Mary K. MorelandExecutive Vice President | Discretionary transaction | 5,314 | Apr 28, 2026 |
| Kevin T. ConroyDirector | Stock award | 2,286 | Apr 24, 2026 |
| Sally E. BlountDirector | Stock award | 2,286 | Apr 24, 2026 |
| Michelle KumbierDirector | Stock award | 2,286 | Apr 24, 2026 |
| Nancy McKinstryDirector | Stock award | 4,591 | Apr 24, 2026 |
| Michael O'GradyDirector | Stock award | 8,215 | Apr 24, 2026 |
| Michael F. RomanDirector | Stock award | 2,286 | Apr 24, 2026 |
| Daniel J. StarksDirector | Stock award | 9,391 | Apr 24, 2026 |
| Nita AhujaDirector | Stock award | 2,286 | Apr 24, 2026 |
Awards, option exercises, shares withheld to cover tax and gifts all file on the same form as a purchase or a sale. None of them is a decision to trade, so they sit here rather than beside the ones that are.
Questions
Are insiders buying or selling ABT?
Across the 13 most recent open-market filings shown here, 4 were purchases and 9 were sales.
Which members of Congress have traded ABT?
Rick W. Allen, Richard McCormick, Mike Kelly, Alan Armstrong, Rick Larsen, Ro Khanna and others disclosed ABT transactions in the filings shown here.
Which members of Congress hold ABT?
18 members of Congress report a position in ABT in the estimate we hold as of Sep 10, 2026. The three largest estimated positions belong to John W. Hickenlooper, J. French Hill and Pete Sessions. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
Is ABT in the S&P 500 or the Nasdaq 100?
Abbott Laboratories is a current member of the S&P 500, per the membership list we hold as of Sep 10, 2026. Current members of either index get a page here whatever their filing history.
How quickly are ABT trades disclosed?
Insider filings on this page reached the public a median of 1 days after the transaction, against the two business days Form 4 allows. Congressional disclosures took a median of 25 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.